Anders Hägg

1.4k total citations
32 papers, 904 citations indexed

About

Anders Hägg is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anders Hägg has authored 32 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anders Hägg's work include Blood Pressure and Hypertension Studies (9 papers), Renal and Vascular Pathologies (9 papers) and Hormonal Regulation and Hypertension (8 papers). Anders Hägg is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Renal and Vascular Pathologies (9 papers) and Hormonal Regulation and Hypertension (8 papers). Anders Hägg collaborates with scholars based in Sweden, United States and United Kingdom. Anders Hägg's co-authors include Lars Lind, Thomas Kahan, Karin Malmqvist, Fredrik H. Nyström, Lisa Kurland, K. Peter Öhman, Jonas Millgård, Håkan Melhus, Julia Karlsson and Håkan Åhlström and has published in prestigious journals such as Hypertension, The Journal of Urology and Thrombosis and Haemostasis.

In The Last Decade

Anders Hägg

31 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Hägg Sweden 16 527 371 196 157 89 32 904
H. Mulec Sweden 18 690 1.3× 581 1.6× 357 1.8× 180 1.1× 73 0.8× 20 1.5k
Paweł Burchardt Poland 16 320 0.6× 151 0.4× 176 0.9× 106 0.7× 100 1.1× 86 798
P.-O. Attman Sweden 18 211 0.4× 317 0.9× 381 1.9× 88 0.6× 47 0.5× 33 964
Ilaria Sestini Italy 10 413 0.8× 126 0.3× 254 1.3× 120 0.8× 48 0.5× 14 653
Fabio Marsico Italy 16 488 0.9× 249 0.7× 238 1.2× 82 0.5× 204 2.3× 44 1.0k
Sean L. Zheng United Kingdom 11 480 0.9× 322 0.9× 237 1.2× 97 0.6× 145 1.6× 27 983
Giulia Dell’Omo Italy 18 722 1.4× 209 0.6× 188 1.0× 173 1.1× 137 1.5× 47 1.3k
GJ Navis Netherlands 14 436 0.8× 203 0.5× 105 0.5× 113 0.7× 76 0.9× 22 917
Axel Åkerblom Sweden 17 745 1.4× 143 0.4× 323 1.6× 60 0.4× 122 1.4× 42 1.1k
Hideaki Jinnouchi Japan 15 722 1.4× 191 0.5× 372 1.9× 114 0.7× 273 3.1× 40 1.3k

Countries citing papers authored by Anders Hägg

Since Specialization
Citations

This map shows the geographic impact of Anders Hägg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Hägg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Hägg more than expected).

Fields of papers citing papers by Anders Hägg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Hägg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Hägg. The network helps show where Anders Hägg may publish in the future.

Co-authorship network of co-authors of Anders Hägg

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Hägg. A scholar is included among the top collaborators of Anders Hägg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Hägg. Anders Hägg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stenborg, A., et al.. (2019). Celiprolol Treatment of Patients With Vascular Ehlers-Danlos Syndrome. European Journal of Vascular and Endovascular Surgery. 58(6). e627–e627. 4 indexed citations
2.
Hennings, Joakim, Anders Sundín, Anders Hägg, & Per Hellman. (2010). 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism. Langenbeck s Archives of Surgery. 395(7). 963–967. 32 indexed citations
3.
Hennings, Joakim, et al.. (2009). Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism. Langenbeck s Archives of Surgery. 395(2). 133–137. 18 indexed citations
4.
Eklöf, Hampus, David Bergqvist, Anders Hägg, & R. Nyman. (2009). Outcome after endovascular revascularization of atherosclerotic renal artery stenosis. Acta Radiologica. 50(3). 256–264. 5 indexed citations
5.
Liss, Per, Hampus Eklöf, Olof Hellberg, et al.. (2005). Renal Effects of CO2 and Iodinated Contrast Media in Patients Undergoing Renovascular Intervention: A Prospective, Randomized Study. Journal of Vascular and Interventional Radiology. 16(1). 57–65. 33 indexed citations
6.
7.
Kurland, Lisa, Håkan Melhus, Jacob Karlsson, et al.. (2002). Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: Results from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) trial. American Journal of Hypertension. 15(5). 389–393. 51 indexed citations
8.
9.
Kurland, Lisa, Håkan Melhus, Julia Karlsson, et al.. (2001). Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. Journal of Hypertension. 19(10). 1783–1787. 98 indexed citations
10.
Malmqvist, Karin, Thomas Kahan, Magnus Edner, et al.. (2001). Regression of left ventricular hypertrophy in human hypertension with irbesartan. Journal of Hypertension. 19(6). 1167–1176. 142 indexed citations
11.
Kahan, Thomas, et al.. (2001). Treatment with irbesartan or atenolol improves endothelial function in essential hypertension. Journal of Hypertension. 19(10). 1813–1818. 41 indexed citations
12.
Millgård, Jonas, Anders Hägg, Thomas Kahan, et al.. (2000). Left Ventricular Hypertrophy is Associated with an Attenuated Endothelium-dependent Vasodilation in Hypertensive Men. Blood Pressure. 9(6). 309–314. 16 indexed citations
13.
Sarabi, Matthieu, Jonas Millgård, Anders Hägg, et al.. (1999). Endothelin plays an important role in the endothelium-dependent vasodilatation in the human forearm. Scandinavian Journal of Clinical and Laboratory Investigation. 59(1). 17–22. 5 indexed citations
14.
Millgård, Jonas, et al.. (1998). Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients. Journal of Human Hypertension. 12(8). 511–516. 34 indexed citations
15.
Hillerdal, Gunnar, et al.. (1991). Intra-Alveolar Haemorrhage in the Anticardiolipin Antibody Syndrome. Scandinavian Journal of Rheumatology. 20(1). 58–62. 28 indexed citations
16.
Hägg, Anders, H Åberg, I Eriksson, L.‐E. Lörelius, & Claes Mörlin. (1987). Fibromuscular dysplasia of the renal artery--management and outcome.. PubMed. 153(1). 15–20. 10 indexed citations
17.
Andersson, Per Ola, et al.. (1986). Role of Surgery in Infective Endocarditis. Acta Medica Scandinavica. 219(3). 275–282. 19 indexed citations
18.
Hägg, Anders, Lars‐Erik Lörelius, Claes Mörlin, & Hans Åberg. (1985). Percutaneous Transluminal Renal Artery Dilatation for Fibromuscular Dysplasia with Special Reference to the Acute Effects on the Renin-Angiotensin-Aldosterone System and Blood Pressure. Scandinavian Journal of Urology and Nephrology. 19(3). 205–209. 2 indexed citations
19.
Lörelius, L.‐E., A. Hemmingsson, Anders Hägg, Claes Mörlin, & H Åberg. (1985). Progressive Fibromusclular Dysplasia of the Renal Artery. Acta Radiologica Diagnosis. 26(6). 705–708. 7 indexed citations
20.
Hägg, Anders, et al.. (1984). Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.. PubMed. 79. 129–32. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Mulec Breakdown of academic impact, for papers by Paweł Burchardt Breakdown of academic impact, for papers by P.-O. Attman Breakdown of academic impact, for papers by Ilaria Sestini Breakdown of academic impact, for papers by Fabio Marsico Breakdown of academic impact, for papers by Sean L. Zheng Breakdown of academic impact, for papers by Giulia Dell’Omo Breakdown of academic impact, for papers by GJ Navis Breakdown of academic impact, for papers by Axel Åkerblom Breakdown of academic impact, for papers by Hideaki Jinnouchi
Rankless by CCL
2026